SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: twt who wrote (1020)1/30/1999 3:48:00 PM
From: Anthony Wong  Respond to of 2539
 
twt, the prescription data does NOT include the seeding, which is why Wall Street was so enthusiastic (about the numbers) last week. I've always been confident that Celebrex will be well received. Next week's scripts should be strong as well. We'll see how it goes.

Scripts usually come out on Monday afternoon or Tuesday morning, unless the media manages to ferret the news out early in the morning.

Last week's Celebrex scripts was provided by NDC Health Information Services. I believe IMS also tracks prescription trends.



To: twt who wrote (1020)1/30/1999 3:49:00 PM
From: coyote  Respond to of 2539
 
when large numbers of samples are handed out (with an Rx if they like the result) You often would not see proof of the Rx being written until the patient runs out of samples. The proof of how good the product is , is when the patient puts his money on the table. Filling after sampling is almost as positive as repeat prescriptions


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News